Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities SGMO - Sangamo Therapeutics, Inc.
14.6 M
LAST VALUE
-33.37%
2 YEAR CAGR
-42.48%
5 YEAR CAGR
-15.23%
10 YEAR CAGR